Senores Pharmaceuticals Share Price
10 Sep, 2026 3:11 PM (IST)
Senores Pharmaceuticals Performance
- Today's Low
- ₹1,461
- Today's High
- ₹1,495
- 52 Week Low
- ₹662
- 52 Week High
- ₹1,599
- Open Price₹1,490
- Previous Close₹1,489
- Volume82,176
- 50 DMA₹1,402.60
- 100 DMA₹1,275.50
- 200 DMA₹1,096.10
Senores Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 8.86%
- Over 3 Month + 33.54%
- Over 6 Month + 97.25%
- Over 1 Year + 98.47%
Smart Investing Starts Here Start SIP with Senores Pharmaceuticals for Steady Growth!
Senores Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 53.3
- PEG Ratio
- 0.6
- Market Cap Cr
- 6,731
- P/B Ratio
- 7
- Average True Range
- 57.1
- EPS
- 27.4
- Dividend Yield
- 0
- MACD Signal
- 17.1
- RSI
- 55.53
- MFI
- 46.08
Latest Stock News Updates
We are submitting herewith the Corrigendum to the Annual Report of the Company for the financial year 2025-26.
- BSE India
- 21 hours 57 minutes ago
We are enclosing herewith the Newspaper Publication for the 9th Annual General Meeting of the Company.
- BSE India
- 6 days 2 hours ago
We are submitting herewith the copy of Business Responsibility and Sustainability Report of the Company for the financial year 2025-26.
- BSE India
- 6 days 22 hours ago
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹1,466.10
- 50 Day
- ₹1,402.60
- 100 Day
- ₹1,275.50
- 200 Day
- ₹1,096.10
Resistance and Support
- R3 1,587.10
- R2 1,556.10
- R1 1,522.30
- S1 1,457.50
- S2 1,426.50
- S3 1,392.70
Senores Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-07-27 | Quarterly Results | |
| 2026-05-14 | Audited Results | |
| 2026-01-20 | Quarterly Results & Others | To consider other business matters. |
| 2026-01-07 | Others | Inter alia, 1. To consider and evaluate proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group. |
| 2025-11-06 | Quarterly Results |
About Senores Pharmaceuticals
Senores Pharmaceuticals is engaged in the business of manufacturing, marketing and trading of pharmaceuticals and allied products and also providing management and consultancy services. View More- NSE Symbol
- SENORES
- BSE Symbol
- 544319
- ISIN
- INE0RB801010
Similar Stocks to Senores Pharmaceuticals
Popular Stocks
Senores Pharmaceuticals FAQs
Senores Pharmaceuticals share price is ₹1,461 As on 10 September, 2026 | 14:58
The Market Cap of Senores Pharmaceuticals is ₹6731.2 Cr As on 10 September, 2026 | 14:58
The P/E ratio of Senores Pharmaceuticals is 53.3 As on 10 September, 2026 | 14:58
The PB ratio of Senores Pharmaceuticals is 7 As on 10 September, 2026 | 14:58
The 52 week High & Low of Senores Pharmaceuticals is ₹1599/₹662.4 respectively As on 10 September, 2026 | 14:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.